While several studies found a positive effect of post-stroke neurogenesis on cognitive outcome, recent results challenge that conclusion, and suggest a maladaptive role
If your starting material is low-purity, filled with contaminants, or has an incorrect amino acid sequence, your research is doomed from the start
Weekly exposure (57 days/week) Weekly Exposure From the 1:1 Pre-blended Vial Daily blend dose 0.5 mg/day Weekly total blend 2.53.5 mg Weekly BPC-157 1.251.75 mg Weekly TB-500 1.251.75 mg Daily blend dose 1.0 mg/day Weekly total blend 5.07.0 mg Weekly BPC-157 2.53.5 mg Weekly TB-500 2.53.5 mg Daily blend dose 1.5 mg/day Weekly total blend 7.510.5 mg Weekly BPC-157 3.755.25 mg Weekly TB-500 3.755.25 mg Daily blend dose 2.0 mg/day Weekly total blend 10.014.0 mg Weekly BPC-157 5.07.0 mg Weekly TB-500 5.07.0 mg Use this to compare a blend schedule against the separate-vial weekly totals in the next tab
PubMed Garvey, W.T., Batterham, R.L., Bhatta, M., Buscemi, S., Christensen, L.N., Frias, J.P., Jdar, E., Kandler, K., Rigas, G., Wadden, T.A., & Wharton, S